These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6697664)

  • 1. The effects of platelet-derived contractile agents on human digital arteries.
    Moulds RF; Iwanov V; Medcalf RL
    Clin Sci (Lond); 1984 Apr; 66(4):443-51. PubMed ID: 6697664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    McGoon MD; Vanhoutte PM
    J Clin Invest; 1984 Sep; 74(3):828-33. PubMed ID: 6470141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K; Yokoyama M; Fukuzaki H
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between platelet-released serotonin and thromboxane A2 on human digital arteries.
    Young MS; Iwanov V; Moulds RF
    Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):143-52. PubMed ID: 3708917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F; David JL; Janssen PA
    Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different interactions of platelets with arterial and venous coronary bypass vessels.
    Yang ZH; Stulz P; von Segesser L; Bauer E; Turina M; Lüscher TF
    Lancet; 1991 Apr; 337(8747):939-43. PubMed ID: 1678031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin.
    De Clerck F; Van Nueten JM
    Thromb Res; 1982 Sep; 27(6):713-27. PubMed ID: 6817452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine.
    Yang BC; Mehta JL
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):387-94. PubMed ID: 7515981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
    Bevan J; Heptinstall S
    Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets.
    Houston DS; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H389-95. PubMed ID: 3156512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet hypersensitivity to serotonin after prolonged ketanserin intake?
    Arnout J; Van Russelt M; Deckmyn H; Vermylen J; Fiocchi R; Lijnen P; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S20-2. PubMed ID: 2412049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.
    De Clerck F; Xhonneux B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S23-5. PubMed ID: 2412050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.
    Ellis EF; Oelz O; Roberts LJ; Payne NA; Sweetman BJ; Nies AS; Oates JA
    Science; 1976 Sep; 193(4258):1135-7. PubMed ID: 959827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
    Nakanishi H; Matsuoka I; Ono T; Nakahata N
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.